During the past decade, York Clinical Research, LLC conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 8 clinical trials were completed, i.e. on average, 38.1% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 6 clinical trials were completed. i.e. 46.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "York Clinical Research, LLC" #1 sponsor was "Ionis Pharmaceuticals, Inc." with 7 trials, followed by "Boehringer Ingelheim" with 6 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored, "Amgen" with 2 trials sponsored and "Kowa Research Institute, Inc." with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "York Clinical Research, LLC" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "Akcea Therapeutics" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "York Clinical Research, LLC" are "Atherosclerotic Cardiovascular Disease" (4 trials), "Atrial Fibrillation" (4 trials), "Hypertension" (4 trials), "Severe Hypertriglyceridemia" (4 trials) and "Atrial Flutter" (2 trials). Many other conditions were trialed in "York Clinical Research, LLC" in a lesser frequency.

Most popular intervention types in "York Clinical Research, LLC" are "Drug" (23 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Apixaban" (3 trials), "Olezarsen" (3 trials), "Empagliflozin" (2 trials) and "Fenofibrate" (2 trials). Other intervention names were less common.

The vast majority of trials in "York Clinical Research, LLC" are 25 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "York Clinical Research, LLC". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in York Clinical Research, LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in York Clinical Research, LLC, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".